Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
July 7, 2026 - 04:02
EQT to acquire parking technology firm OrikanEQT has announced its acquisition of Orikan, a company known for providing parking and compliance technology. The deal is aimed at accelerating growth, advancing artificial intelligence...
July 6, 2026 - 19:57
Toward a future that preserves benefits of neurotechnology for allA researcher from the Harvard-MIT Health Science and Technology program has won a major prize for her vision of how brain-computer interfaces could shape society. Rachel Sava, a PhD candidate, took...
July 6, 2026 - 11:42
AI Job Disruption Has Come for Ireland's Technology SectorIreland`s technology sector, which enjoyed a prolonged jobs boom fueled by a wave of US multinationals setting up European headquarters, is now facing a sharp reversal. The very force that helped...
July 5, 2026 - 20:48
Market Dispersion Rises as Technology Leadership FadesInvestors are watching a shift in market dynamics as the once-dominant technology sector shows signs of losing its grip on leadership. Market dispersion, a measure of how widely stock returns vary...